Hoth Therapeutics rises as it expands AI push with Nvidia licenses

Rocket One

08/10/2025 13:36

** Hoth Therapeutics' HOTH.O shares rise 8.5% to $1.66 premarket

** Co expands AI initiative, secures Nvidia NVDA.O AI Enterprise licenses to support GPU-powered drug research

** Platform to help simulate trials, predict toxicity and integrate patient data for faster drug development - HOTH

** HOTH will also use the technology to simulate clinical trials and monitor patient responses in real time

** AI push part of broader digital strategy to cut costs and improve outcomes - HOTH

** Up to last close, stock up 105% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))